Hypertrophic Cardiomyopathy Secondary to RAF1 Cysteine-Rich Domain Variants

Circ Genom Precis Med. 2023 Dec;16(6):e004262. doi: 10.1161/CIRCGEN.123.004262. Epub 2023 Oct 31.

Authors

Affiliations

¹ Center for Genetic Medicine (D.E.F., I.M.S., J.R.J., L.M.D.-C., E.M.M.), Northwestern University, Chicago, IL.
² Division of Cardiology, Department of Medicine (D.E.F., A.S., L.M.D.-C., L.C., E.M.M., L.D.W.), Northwestern University, Chicago, IL.
³ Feinberg Cardiovascular and Renal Research Institute (R.M.J., D.F.L., L.D.W.), Northwestern University, Chicago, IL.
⁴ Department of Pharmacology, Feinberg School of Medicine (L.D.W.), Northwestern University, Chicago, IL.

No abstract available

Keywords: Noonan syndrome; epidermal growth factor; humans; immunoblotting; phosphorylation.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Cardiomyopathy, Hypertrophic* / complications
Cardiomyopathy, Hypertrophic* / genetics
Cysteine
Humans
Noonan Syndrome*

Substances

Cysteine

Grants and funding